Product Info Summary
SKU: | A11525-2 |
---|---|
Size: | 100ul |
Reactive Species: | Human, Mouse |
Host: | Rabbit |
Application: | ELISA, IF, IHC, WB |
Customers Who Bought This Also Bought
Product info
Product Name
Anti-APBA2BP NECAB3 Antibody
SKU/Catalog Number
A11525-2
Size
100ul
Form
Liquid
Description
Boster Bio Anti-APBA2BP NECAB3 Antibody catalog # A11525-2. Tested in ELISA, IF, IHC, WB applications. This antibody reacts with Human, Mouse.
Storage & Handling
Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
Cite This Product
Anti-APBA2BP NECAB3 Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # A11525-2)
Host
Rabbit
Contents
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Isotype
IgG
Immunogen
The antiserum was produced against synthesized peptide derived from human NECAB3. AA range:321-370
*Blocking peptide can be purchased. Costs vary based on immunogen length. Contact us for pricing.
Reactive Species
A11525-2 is reactive to NECAB3 in Human, Mouse
Reconstitution
Calculated molecular weight
44350 MW
Antibody Validation
Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.
Application & Images
Applications
A11525-2 is guaranteed for ELISA, IF, IHC, WB Boster Guarantee
Assay Dilutions Recommendation
The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.
WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:40000
Validation Images & Assay Conditions
Click image to see more details
Figure 1. Western blotting validation for Anti-APBA2BP NECAB3 Antibody A11525-2
Western Blot (WB) analysis of specific cells using APBA2BP polyclonal antibody.Electrophoresis was performed on a SDS-PAGE gel. To determine SDS-PAGE gel concentration
Protein Target Info & Infographic
Gene/Protein Information For NECAB3 (Source: Uniprot.org, NCBI)
Gene Name
NECAB3
Full Name
N-terminal EF-hand calcium-binding protein 3
Weight
44350 MW
Alternative Names
N-terminal EF-hand calcium-binding protein 3;Amyloid-beta A4 protein-binding family A member 2-binding protein;Nek2-interacting protein 1;Neuronal calcium-binding protein 3;X11L-binding protein 51;NECAB3;APBA2BP, NIP1, SYTIP2, XB51;
*If product is indicated to react with multiple species, protein info is based on the gene entry specified above in "Species".For more info on NECAB3, check out the NECAB3 Infographic
We have 30,000+ of these available, one for each gene! Check them out.
In this infographic, you will see the following information for NECAB3: database IDs, superfamily, protein function, synonyms, molecular weight, chromosomal locations, tissues of expression, subcellular locations, post-translational modifications, and related diseases, research areas & pathways. If you want to see more information included, or would like to contribute to it and be acknowledged, please contact [email protected].
Specific Publications For Anti-APBA2BP NECAB3 Antibody (A11525-2)
Hello CJ!
No publications found for A11525-2
*Do you have publications using this product? Share with us and receive a reward. Ask us for more details.
Recommended Resources
Here are featured tools and databases that you might find useful.
- Boster's Pathways Library
- Protein Databases
- Bioscience Research Protocol Resources
- Data Processing & Analysis Software
- Photo Editing Software
- Scientific Literature Resources
- Research Paper Management Tools
- Molecular Biology Software
- Primer Design Tools
- Bioinformatics Tools
- Phylogenetic Tree Analysis
Customer Reviews
Have you used Anti-APBA2BP NECAB3 Antibody?
Submit a review and receive an Amazon gift card.
- $30 for a review with an image
0 Reviews For Anti-APBA2BP NECAB3 Antibody
Customer Q&As
Have a question?
Find answers in Q&As, reviews.
Can't find your answer?
Submit your question